Singapore · Delayed Price · Currency is SGD HGH Holdings Statistics
Total Valuation
HGH Holdings has a market cap or net worth of SGD 33.84 million. The enterprise value is 45.06 million.
| Market Cap | 33.84M |
| Enterprise Value | 45.06M |
Important Dates
The next estimated earnings date is Saturday, August 22, 2026.
| Earnings Date | Aug 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HGH Holdings has 1.78 billion shares outstanding. The number of shares has increased by 5.04% in one year.
| Current Share Class | 1.78B |
| Shares Outstanding | 1.78B |
| Shares Change (YoY) | +5.04% |
| Shares Change (QoQ) | +5.29% |
| Owned by Insiders (%) | 58.74% |
| Owned by Institutions (%) | 8.62% |
| Float | 734.75M |
Valuation Ratios
The trailing PE ratio is 4.23.
| PE Ratio | 4.23 |
| Forward PE | n/a |
| PS Ratio | 0.44 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.60 |
| P/FCF Ratio | 61.21 |
| P/OCF Ratio | 15.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.91, with an EV/FCF ratio of 81.50.
| EV / Earnings | 5.58 |
| EV / Sales | 0.59 |
| EV / EBITDA | 2.91 |
| EV / EBIT | 4.50 |
| EV / FCF | 81.50 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.54 |
| Quick Ratio | 1.52 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.06 |
| Debt / FCF | 29.54 |
| Interest Coverage | 21.00 |
Financial Efficiency
Return on equity (ROE) is 15.99% and return on invested capital (ROIC) is 12.60%.
| Return on Equity (ROE) | 15.99% |
| Return on Assets (ROA) | 6.95% |
| Return on Invested Capital (ROIC) | 12.60% |
| Return on Capital Employed (ROCE) | 13.59% |
| Weighted Average Cost of Capital (WACC) | 5.09% |
| Revenue Per Employee | 354,062 |
| Profits Per Employee | 37,372 |
| Employee Count | 216 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 199.39 |
Taxes
In the past 12 months, HGH Holdings has paid 1.49 million in taxes.
| Income Tax | 1.49M |
| Effective Tax Rate | 14.79% |
Stock Price Statistics
The stock price has decreased by -20.83% in the last 52 weeks. The beta is 0.38, so HGH Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -20.83% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 59.18 |
| Average Volume (20 Days) | 2,457,215 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HGH Holdings had revenue of SGD 76.48 million and earned 8.07 million in profits. Earnings per share was 0.00.
| Revenue | 76.48M |
| Gross Profit | 19.15M |
| Operating Income | 10.01M |
| Pretax Income | 10.04M |
| Net Income | 8.07M |
| EBITDA | 15.06M |
| EBIT | 10.01M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 8.04 million in cash and 16.33 million in debt, with a net cash position of -8.29 million or -0.00 per share.
| Cash & Cash Equivalents | 8.04M |
| Total Debt | 16.33M |
| Net Cash | -8.29M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 59.37M |
| Book Value Per Share | 0.03 |
| Working Capital | 16.89M |
Cash Flow
In the last 12 months, operating cash flow was 2.21 million and capital expenditures -1.66 million, giving a free cash flow of 552,836.
| Operating Cash Flow | 2.21M |
| Capital Expenditures | -1.66M |
| Depreciation & Amortization | 5.05M |
| Net Borrowing | 3.69M |
| Free Cash Flow | 552,836 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 25.04%, with operating and profit margins of 13.08% and 10.56%.
| Gross Margin | 25.04% |
| Operating Margin | 13.08% |
| Pretax Margin | 13.13% |
| Profit Margin | 10.56% |
| EBITDA Margin | 19.69% |
| EBIT Margin | 13.08% |
| FCF Margin | 0.72% |
Dividends & Yields
HGH Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.04% |
| Shareholder Yield | -5.04% |
| Earnings Yield | 23.86% |
| FCF Yield | 1.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 25, 2016. It was a forward split with a ratio of 5.359056806.
| Last Split Date | Nov 25, 2016 |
| Split Type | Forward |
| Split Ratio | 5.359056806 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |